Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29906263 | 1.00 | TDO2 (0.33) | TDO2PTGS2 | |
| SCHEMBL14647324 | 0.88 | PTGS2 (0.31) | PTGS2 | |
| SCHEMBL3742137 | 0.88 | PDE4B (0.39) | PTGS2 | |
| SCHEMBL3740813 | 0.88 | TDO2 (0.33) | TDO2 | |
| SCHEMBL29992179 | 0.88 | PTGS2 (0.31) | PTGS2 | |
| SCHEMBL25334895 | 0.87 | PTGS2 (0.38) | PTGS2 | |
| SCHEMBL31179832 | 0.87 | PTGS2 (0.38) | PTGS2 | |
| SCHEMBL20165772 | 0.84 | PTGS2 (0.32) | PTGS2 | |
| SCHEMBL29873688 | 0.84 | PTGS2 (0.32) | PTGS2 | |
| SCHEMBL22687558 | 0.84 | TDO2 (0.31) | TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250145650-A1 | C1 Symmetric 5-OMe-6-alkyl Substituted Metallocenes | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-05-08 | — | — | US | disclosed |
| CN-118891293-A | C1 symmetrical 5-OMe-6-alkyl substituted metallocenes | 埃克森美孚化学专利公司 | 2024-11-01 | — | — | CN | disclosed |
| US-11952481-B2 | Heterophasic polypropylene composition with high flexibility and softness | BOREALIS AG (AT) | 2024-04-09 | — | — | US | disclosed |
| CN-111527140-B | Heterophasic polypropylene composition with high flexibility and high softness | 北欧化工公司 | 2023-11-17 | — | — | CN | disclosed |
| US-11807655-B2 | Catalysts | BOREALIS AG (AT) | 2023-11-07 | — | — | US | disclosed |
| US-11807655-B2 | Catalysts | BOREALIS AG (AT) | 2023-11-07 | — | — | US | disclosed |
| US-11807655-B2 | Catalysts | BOREALIS AG (AT) | 2023-11-07 | — | — | US | disclosed |
| WO-2023150480-A1 | C1 SYMMETRIC 5-OME-6-ALKYL SUBSTITUTED METALLOCENES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| US-11702487-B2 | Process for preparing propylene polymers | BOREALIS AG (AT) | 2023-07-18 | — | — | US | disclosed |
| US-11702487-B2 | Process for preparing propylene polymers | BOREALIS AG (AT) | 2023-07-18 | — | — | US | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-9187583-B2 | Catalysts | BOREALIS AG (AT) | 2015-11-17 | — | — | US | disclosed |
| US-9187583-B2 | Catalysts | BOREALIS AG (AT) | 2015-11-17 | — | — | US | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| EP-2729479-A1 | CATALYSTS | Borealis AG (AT) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013007650-A1 | CATALYSTS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |
| WO-2013007650-A1 | CATALYSTS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145650-A1 | C1 Symmetric 5-OMe-6-alkyl Substituted Metallocenes | RPS6, IMPA1, C1S | TDO2 2679/4885PTGS2 1272/4885 |
| US-11807655-B2 | Catalysts | SOD1, MT-CO2, MT-CO1 | TDO2 2817/4885PTGS2 2491/4885 |
| US-20160024123-A1 | Asymmetrical Ligands | CCRL2, AR, CCR2 | TDO2 1604/4885PTGS2 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.